Donaldson Company, Inc. (NYSE:DCI – Get Free Report) insider Amy C. Becker sold 14,500 shares of the business’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $72.89, for a total transaction of $1,056,905.00. Following the transaction, the insider now owns 41,368 shares in the company, valued at $3,015,313.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Donaldson Trading Up 1.1 %
Shares of NYSE:DCI opened at $73.47 on Wednesday. The business’s 50 day simple moving average is $72.43 and its 200 day simple moving average is $72.90. Donaldson Company, Inc. has a 1 year low of $57.05 and a 1 year high of $78.03. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.23. The company has a market capitalization of $8.85 billion, a P/E ratio of 22.75, a P/E/G ratio of 1.84 and a beta of 1.05.
Donaldson (NYSE:DCI – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The industrial products company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.06. Donaldson had a net margin of 11.54% and a return on equity of 29.47%. The business had revenue of $935.40 million during the quarter, compared to analysts’ expectations of $941.12 million. On average, research analysts anticipate that Donaldson Company, Inc. will post 3.63 EPS for the current fiscal year.
Donaldson Dividend Announcement
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. Raymond James started coverage on shares of Donaldson in a research note on Friday, June 28th. They set a “market perform” rating on the stock. Robert W. Baird decreased their price target on shares of Donaldson from $80.00 to $79.00 and set an “outperform” rating on the stock in a research note on Monday, June 3rd. StockNews.com cut Donaldson from a “strong-buy” rating to a “buy” rating in a report on Friday, September 20th. Finally, Stifel Nicolaus dropped their target price on Donaldson from $76.00 to $71.00 and set a “hold” rating for the company in a report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $69.67.
View Our Latest Analysis on Donaldson
Hedge Funds Weigh In On Donaldson
Hedge funds and other institutional investors have recently modified their holdings of the business. Park Place Capital Corp acquired a new stake in Donaldson in the first quarter valued at about $27,000. YHB Investment Advisors Inc. bought a new position in shares of Donaldson in the first quarter worth about $32,000. Versant Capital Management Inc boosted its stake in shares of Donaldson by 1,372.2% in the 2nd quarter. Versant Capital Management Inc now owns 530 shares of the industrial products company’s stock valued at $38,000 after purchasing an additional 494 shares in the last quarter. Mather Group LLC. grew its holdings in shares of Donaldson by 408.1% during the 2nd quarter. Mather Group LLC. now owns 503 shares of the industrial products company’s stock valued at $38,000 after purchasing an additional 404 shares during the last quarter. Finally, Riverview Trust Co acquired a new position in Donaldson during the 1st quarter worth approximately $46,000. Institutional investors own 82.81% of the company’s stock.
Donaldson Company Profile
Donaldson Company, Inc manufactures and sells filtration systems and replacement parts worldwide. The company operates through three segments: Mobile Solutions, Industrial Solutions, and Life Sciences. Its Mobile Solutions segment provides replacement filters for air and liquid filtration applications, such as air filtration systems; liquid filtration systems for fuel, lube, and hydraulic applications; exhaust and emissions systems and sensors; indicators; and monitoring systems.
See Also
- Five stocks we like better than Donaldson
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Invest in Insurance Companies: A Guide
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Donaldson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Donaldson and related companies with MarketBeat.com's FREE daily email newsletter.